Long
EOS Token with Leverage (8X, 400%+ Potential Profits)

We have a beautiful setup here for EOS Token (EOSM20) and we are active with 8X leverage... This is for advanced/experienced traders only.
Prices are moving above EMA50 and EMA10.
We have a bullish cross on the MACD and a strong RSI.
These signals are pointing to a potential bullish move.
We have a full trade active now. If you would like to see all the details (buy-in, targets, stop-loss, and additional information), make sure to hit LIKE.
We will share at 100 likes.
Thanks a lot for reading.
Namaste.
Prices are moving above EMA50 and EMA10.
We have a bullish cross on the MACD and a strong RSI.
These signals are pointing to a potential bullish move.
We have a full trade active now. If you would like to see all the details (buy-in, targets, stop-loss, and additional information), make sure to hit LIKE.
We will share at 100 likes.
Thanks a lot for reading.
Namaste.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
Pubblicazioni correlate
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.


